Fabrazyme (Genzyme Corporation)
Welcome to the PulseAid listing for the Fabrazyme drug offered from Genzyme Corporation. This alpha-Glucosidases [Chemical/Ingredient],Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Genzyme Corporation |
| NON-PROPRIETARY NAME: | AGALSIDASE BETA |
| SUBSTANCE NAME: | AGALSIDASE BETA |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | alpha-Glucosidases [Chemical/Ingredient],Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2008-12-17 |
| END MARKETING DATE: | 0000-00-00 |
Fabrazyme HUMAN PRESCRIPTION DRUG Details:
| Item Description | Fabrazyme from Genzyme Corporation |
| LABELER NAME: | Genzyme Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/mL) |
| START MARKETING DATE: | 2008-12-17 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 58468-0040_1062d32d-80a0-43eb-b5fa-78c3ea27504e |
| PRODUCT NDC: | 58468-0040 |
| APPLICATION NUMBER: | BLA103979 |
Other AGALSIDASE BETA Pharmaceutical Manufacturers / Labelers:
